ITGB7 and inflammatory bowel disease: Moreover, none of our patients suffered from IBD, so the molecules we investigated are a reflection of changes present only in PSO and LP, not affected by IBD for which MAdCAM–ITGB7 interactions have been probably most prominently described so far.